KRYS News and Press, Krystal Biotech Inc. From 07/01/19

Introduction Every year the Russell Indexes are rebalanced to bring in new stocks and remove underperforming stocks. The FTSE Russell calls this event the annual reconstitution process, and it begins with evaluations in May and moves to the selection process on June 7th with the newly recons...

Introduction Every year the Russell Indexes are rebalanced to bring in new stocks and remove underperforming stocks. The FTSE Russell calls this event the annual reconstitution process, and it begins with evaluations in May and moves to the selection process on June 7th with the newly recons...

PITTSBURGH, July 01, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company developing medicines to treat skin diseases, today announces that it has been added to the Russell 2000 ®  Index, effective after the stock mark...

PITTSBURGH, July 01, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company developing medicines to treat skin diseases, today announces that it has been added to the Russell 2000 ®  Index, effective after the stock mark...

Krystal Biotech (NASDAQ: KRYS ) has priced its public offering of 2.5M common shares at $40/share, for gross proceeds of ~$100M. More news on: Krystal Biotech, Inc., Healthcare stocks news, Read more ...

PITTSBURGH, June 24, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (Nasdaq: KRYS) (the “Company”), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases, today announced that it has priced the...

PITTSBURGH, June 24, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech , Inc. (Nasdaq: KRYS) (the “Company”), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases, today announced that it has commenced ...

Gainers:  VivoPower International (NASDAQ: VVPR ) +108% . Minerva Neurosciences (NASDAQ: NERV ) +43% . PCM (NASDAQ: PCMI ) +42% . Krystal Biotech (NASDAQ: KRYS ) +30% . NRC Group Holdings (NYSEMKT: NRCG ) +26% . India Globalization Capital (NYSEMKT: IGC ) +21% . Rekor Systems (R...

Thinly traded Krystal Biotech ( KRYS +26.8% ) is up on more than triple normal volume, albeit on turnover of only 370K shares, on the heels of positive data from a Phase 2 clinical trial, GEM-2, evaluating topical gene therapy candidate KR103 in patients with a rare inherited skin disord...

Minerva Neurosciences (NASDAQ: NERV ) +58%  on positive results from a Phase 2b clinical trial,  ISM2005 , evaluating seltorexant (MIN-202) in patients with insomnia disorder. More news on: Minerva Neurosciences, Inc., PCM, Inc., Krystal Biotech, Inc., Stocks on the move, ...